Hashimoto's thyroiditis and the association of cy¬ totoxic antibody activity with the microsomal anti¬ body fraction, it has been generally accepted that the presence of these antibodies is an indicator of thyroid cell destruction (1-4). Nevertheless, clinical follow-up studies showed that in some patients microsomal antibodies are present for many years without development of hypothyroidism (5, 6) . Preliminary data of our laboratory suggest that there is no correlation between cytotoxic antibody activity and titres of microsomal antibodies (7). In this paper we add further evidence for the diversity of cytotoxic and microsomal/thyroid peroxidase antibodies.
tion technique (r=0.2), enzyme immunoassay with microsomal antigen (r=0.16), and radioimmunoassay for thyroid peroxidase antibody (r=0.02). The cytotoxic activity was located in the IgG fraction, both in microsomal antibody positive and negative sera. After pre-incubation of microsomal antibody/thyroid peroxidase antibody positive or negative sera with purified thyroid peroxidase followed by analysis in the antibody-dependent cell-mediated cytotoxicity assay, cytotoxicity decreased in only 2 cases but was unchanged in the remaining sera. Western blot experiments with solubilized thyroid membranes and immunoblotting with cytotoxic-positive/microsomal antibody negative sera showed no binding to thyroid peroxidase. Our data suggest that cytotoxicity in sera from patients with Hashimoto's thyroiditis is not mediated by antibodies against thyroid peroxidase, but by antibodies not yet identified.
Since the detection of microsomal antibodies in
Hashimoto's thyroiditis and the association of cy¬ totoxic antibody activity with the microsomal anti¬ body fraction, it has been generally accepted that the presence of these antibodies is an indicator of thyroid cell destruction (1) (2) (3) (4) . Nevertheless, clinical follow-up studies showed that in some patients microsomal antibodies are present for many years without development of hypothyroidism (5, 6) . Preliminary data of our laboratory suggest that there is no correlation between cytotoxic antibody activity and titres of microsomal antibodies (7) . In this paper we add further evidence for the diversity of cytotoxic and microsomal/thyroid peroxidase antibodies.
Patients and Methods
Sixty-seven patients with autoimmune thyroiditis were studied, 57 women and 10 men, aged 21-83 years (mean 55). The Mi-ab/Tg-ab negative group 36.9 and 33.6%, re¬ spectively (Fig. 3) .
To investigate in more detail whether the cyto¬ toxic antibody is different from the TPO antibod¬ ies, sera with positive and negative titres of TPOab, but positive results for cytotoxicity, were preincubated with purified TPO for 2 h and then added to the ADCC assay. The cytotoxic activity remained unchanged in 7 of 9 sera, irrespective of whether they had a positive or a negative result for TPO-ab ( Fig. 4) 
Discussion
Two different immunological reactions were used in the past to determine antibody-mediated cyto¬ toxicity in patients with Hashimoto's thyroiditis: 1. antibody-dependent complement-mediated cytoto¬ xicity and 2. antibody-dependent cell-mediated cy¬ totoxicity.
Using an antibody-dependent complement-medi¬ ated cytotoxicity assay, Pulvertaft et al. (1, 2) de¬ scribed for the first time in sera from patients with Hashimoto's thyroiditis a cytotoxic factor which in¬ duced lysis of cultured thyroid cells. Further inves¬ tigations showed that this factor is located in the microsomal antibody fraction, that the effect is abolished by heat-inactivation to 56°C, and that it can be reinstalled by the addition of fresh comple¬ ment (3, 4) . Absorption experiments with thyroglo¬ bulin proved that cytotoxic and thyroglobulin an¬ tibodies are not identical (1, 9) . Some authors found a positive cytotoxic effect in sera of patients with Hashimoto's thyroiditis, whereas their titres of microsomal antibodies were negative and vice versa (1, 9) . Chandler et al. (10) found no correlation be¬ tween complement-mediated cytotoxicity and titres of microsomal antibodies and suggested that the cytotoxic effect is mediated by a factor independent of the microsomal antibodies. In contrast, Khoury et al. (11) demonstrated thyroid cell lysis with microsomal antibody positive sera, and recently Wadeleux et al. (12) likewise showed thyroid cell damage owing to antibody-dependent comple¬ ment-mediated cytotoxicity which correlated to the titres of the microsomal antibodies. Although the data of the studies are not uniform, it has been generally accepted that the cytotoxic factor is lo¬ cated in the microsomal antibody fraction.
In accordance with the results of complementmediated cell lysis, studies analysing cytotoxic effects by means of antibody-dependent cell-medi¬ ated cytotoxicity assays also showed a higher fre¬ quency of positive results in patients with Hashi¬ moto's thyroiditis; unfortunately, the titres of the microsomal antibodies were not simultaneously re¬ ported (13) (14) (15) . Earlier data obtained in our labo¬ ratory by applying an ADCC assay with cultured human thyroid cells as targets indicated a simulta¬ neous occurrence of cell lysis and microsomal an¬ tibodies (8) . In a larger group of patients, however, we could no longer detect any correlation between cytotoxicity and microsomal antibody activity, which emphasizes the biases associated with inves¬ tigating small collectives. These results are in agree¬ ment with previously published data of patients with Graves' disease in whom we were likewise unable to find a connection between cytotoxicity and microsomal antibody activity (7) .
The microsomal antigen has now been identified as thyroid peroxidase (16, 17) . To (20) .
In conclusion, our data give evidence that, be¬ sides the well-known thyroid autoantibodies, a fur¬ ther antibody exists which is responsible for thyroid cell destruction in autoimmune thyroid disease. This antibody can occur either alone or together with the other autoantibodies and might, in some cases, be the only factor to prove the autoimmune pathogenesis of the disease. Further studies are in progress to support the hypothesis of the diversity of cytotoxic and thyroid peroxidase antibodies.
